Monopar Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients.

Biotechnology

Monopar Therapeutics

Monopar Therapeutics' headquarters in Wilmette, IL, United States

Chandler D. Robinson

Octávio Costa

Andrew P. Mazar

Andrew Cittadine

Kim R. Tsuchimoto

Michael J. Brown

Raymond W. Anderson

Arthur Klausner

Christopher M. Starr

The Finance and Accounting team at Monopar Therapeutics is responsible for managing the company's financial health by overseeing budgeting, forecasting, and financial reporting. They ensure compliance with regulatory standards, manage cash flow, and support strategic decision-making to facilitate the development of innovative therapeutics for cancer patients. Their efforts provide vital fiscal insights and maintain the integrity of financial operations within the organization.

Finance and Accounting

The Leadership Team at Monopar Therapeutics is responsible for guiding the strategic direction and overall operations of the company. Composed of key executives with expertise in research, development, finance, and medical affairs, this team collaborates to drive innovative therapeutics for cancer patients, ensure regulatory compliance, and manage organizational growth, ultimately enhancing patient outcomes and extending life.

Leadership Team

The Project Management and Operations team at Monopar Therapeutics is responsible for overseeing the planning, execution, and monitoring of clinical projects, ensuring that timelines and budgets are met. They collaborate closely with cross-functional teams to streamline operations, optimize resources, and maintain compliance with regulatory standards, ultimately supporting the development of innovative therapies for cancer patients.

Monopar Therapeutics

Org chart

Board & advisors

Teams

Finance and Accounting

Leadership Team

Project Management and Operations

Offices

Similar companies